A survey, conducted in collaboration with the online community SheSpeaks, showed the company that its prospective consumers need further information on safety, price and results.
The latest joint report from the Physicians Coalition for Injectable Safety and the Partnership for Safe Medicines tallies up instances of counterfeit product sales and unlicensed practitioners in the segment.
The USFDA yesterday confirmed that it has approved of Botox Cosmetic for the temporary treatment of fine lines around the eye area, commonly known as crow’s feet.
Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
California-based Allergan Inc has had its in-vitro, cell-based assay for testing the stability and potency of Botox and Botox cosmetic, approved by the FDA.
US company Sanofi-avantis says its Sculptra Aesthetic facial injection treatments targeting smile lines and other deep wrinkles have been given FDA approval.
The FDA has agreed to evaluate an anti-wrinkle injection treatment
from France-based pharmaceutical company Ipsen which if approved
would provide a rival for Allergan's Botox.
Mentor Corporation says it has begun a Phase 2 dose-finding study
for its botulinum toxin type A product focused on cosmetic
indications in the US - a move that aims to tap into the still
growing market for non-surgical anti-aging...
Mentor, a global supplier of medical products, says it has
initiated an initial study of its proprietary botulinum toxin type
A product, focused on the cosmetic applications for the US market.
The company says that the study aims...
Irish neuroscience based biopharmaceuticals company Elan has sold
its botulinum toxin type B product Myobloc/Neurobloc to Solstice
Neurosciences for up to €15 million.